The Management of Soft Tissue Sarcomas
Soft tissue sarcomas present in a wide variety of locations and span a wide variety of locations. This makes the management of these tumors challenging. However, there are a number of well-known principles that can be considered in the planning of treatment of these tumors. Although these tumors involve many sites, the primary focus of this review will be on extremity and retroperitoneal locations. The importance of a coordinated multi-disciplinary team cannot be under-estimated in the treatment planning process. This course will discuss issues of specific tumor pathology, tumor location issues, treatment set-up factors, clinical tumor volumes, and techniques, as well as other special considerations in the approach to this diverse group of cancers. Evaluation and follow-up as well as surgical and systemic therapeutic integration will be briefly covered as well as treatment complications.
This program is designed to meet the interest of radiation oncologists, radiation therapists, dosimetrists and radiation oncology residents.
- Identify tumors more responsive to radiation and chemotherapy.
- Define appropriate volumes for both extremity and retroperitoneal sarcomas.
- Determine the appropriate integration of multimodality therapy in different sarcoma scenarios.
- Ivy A. Petersen, MD, is employed at Mayo Clinic and holds a leadership position with the NRG Oncology and has no financial relationships with a commercial interest.
The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.00 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
- Nonmember: $105
- Member: $55
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.
Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.